The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor-Reference-Cited by-同舟云学术

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor

Published:2020-08 Issue: Volume:128 Page:110249
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Capurro Valeria,Lanfranco Massimiliano,Summa Maria,Porceddu Pier Francesca,Ciampoli Mariasole,Margaroli Natasha,Durando Lucia,Garrone Beatrice,Ombrato Rosella,Tongiani Serena,Reggiani Angelo

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference21 articles.

1. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials;Geddes;Am. J. Psychiatry,2004

2. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3;Gould;Neuropsychopharmacology.,2004

3. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases;Beurel;Pharmacol. Ther.,2015

4. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades;Wada;J. Pharmacol. Sci.,2009

5. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium;O’Brien;J. Neurosci.,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined in vivo effect of N-acylethanolamine-hydrolyzing acid amidase and glycogen synthase kinase-3β inhibition to treat multiple sclerosis;Biomedicine & Pharmacotherapy;2024-06

2. Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies;Frontiers in Psychiatry;2024-01-08

3. Genomic profile of Parkinson's disease in Asians;Clinica Chimica Acta;2024-01

4. New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis;PeerJ;2023-12-12

5. Role of microtubule actin crosslinking factor 1 (MACF1) in bipolar disorder pathophysiology and potential in lithium therapeutic mechanism;Translational Psychiatry;2023-06-23